Telescope Innovations Corp. (CSE:TELI)

Market Cap	17.99M
Revenue (ttm)	4.13M
Net Income (ttm)	-1.88M
Shares Out	53.70M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,500
Average Volume	18,801
Open	0.350
Previous Close	0.330
Day's Range	0.335 - 0.360
52-Week Range	0.280 - 0.550
Beta	1.53
RSI	32.98
Earnings Date	Jan 27, 2025

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. is based in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Henry Dubina
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TELI

Financial Performance

In 2024, Telescope Innovations's revenue was 4.43 million, an increase of 56.80% compared to the previous year's 2.82 million. Losses were -1.32 million, 84.3% more than in 2023.